Avivagen Inc. is a Canada-based development-stage biotechnology company. The Company is engaged in developing science-based, natural health products for animals that are proven in clinical trials. The Company is focused on the development of products from the oxidation of carotenoids based on its OxC-Beta (oxidized carotenoid) technology. It is developing and delivering non-antibiotic feed supplements for optimal livestock productivity. The Company's commercial products are OxC-beta for livestock, Vivamune Health Chews and Oximunol Chewables for dogs and cats. The Company's technologies are based on Natural Health Optimizers (NHOs). The Company has organized into two segments: OxC-Beta product sales and chemistry services sales.